Avadel Pharmaceuticals Plc (AVDL)
21.64
0.00 (0.00%)
USD |
NASDAQ |
Sep 02, 16:00
Avadel Pharmaceuticals Research and Development Expense (Annual)
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2024 | 15.20M |
| December 31, 2023 | 13.26M |
| December 31, 2022 | 20.70M |
| December 31, 2021 | 17.10M |
| December 31, 2020 | 20.44M |
| December 31, 2019 | 32.92M |
| December 31, 2018 | 39.33M |
| December 31, 2017 | 33.42M |
| December 31, 2016 | 34.61M |
| December 31, 2015 | 25.61M |
| December 31, 2014 | 22.80M |
| December 31, 2013 | 21.77M |
| December 31, 2012 | 26.12M |
| Date | Value |
|---|---|
| December 31, 2011 | 25.09M |
| December 31, 2010 | 28.69M |
| December 31, 2009 | 30.42M |
| December 31, 2008 | 36.25M |
| December 31, 2007 | 43.56M |
| December 31, 2006 | 38.23M |
| December 31, 2005 | 47.30M |
| December 31, 2004 | 35.36M |
| December 31, 2003 | 20.22M |
| December 31, 2002 | 12.24M |
| December 31, 2001 | 10.66M |
| December 31, 2000 | 9.789M |
| December 31, 1999 | 11.05M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Jazz Pharmaceuticals Plc | 782.74M |
| Perrigo Co. Plc | 95.40M |
| GH Research Plc | 38.73M |
| Cosmo NV | 36.21M |
| Alkermes Plc | 318.36M |